Showing results (31-40 of 50) with videos related to
Sort By:
Pageof 5
Plos One|June 16, 2011
p53 transactivation and the impact of mutations, cofactors and small molecules using a simplified yeast-based screening systemVirginia Andreotti, Yari Ciribilli, Paola Monti, et al.Cell Death & Disease|July 28, 2021
ETV7 regulates breast cancer stem-like cell features by repressing IFN-response genesLaura Pezzè, Erna Marija Meškytė, Mattia Forcato, et al.Oncogene|August 15, 2003
Characterization of the p53 mutants ability to inhibit p73 beta transactivation using a yeast-based functional assayPaola Monti, Paola Campomenosi, Yari Ciribilli, et al.Molecules (Basel, Switzerland)|August 15, 2018
Synthesis of 2,6-Diamino-Substituted Purine Derivatives and Evaluation of Cell Cycle Arrest in Breast and Colorectal Cancer CellsBartolomeo Bosco, Andrea Defant, Andrea Messina, et al.Cancers|April 14, 2026
p53 Isoforms as Modifiers of the p53-Dependent Responses: A Hidden Code?Laura Bartolomei, Beatrice Pretto, Samuele Brugnara, et al.Molecular Cancer Research : MCR|February 24, 2011
Dominant-negative features of mutant TP53 in germline carriers have limited impact on cancer outcomesPaola Monti, Chiara Perfumo, Alessandra Bisio, et al.DNA Repair|January 10, 2008
Rev1 and Polzeta influence toxicity and mutagenicity of Me-lex, a sequence selective N3-adenine methylating agentPaola Monti, Yari Ciribilli, Debora Russo, et al.Seminars in Oncology|September 6, 2023
Oral selective estrogen receptor degraders (SERDs): The new emperors in breast cancer clinical practice?Antonella Ferro, Daniele Generali, Orazio Caffo, et al.Journal of Clinical Medicine|June 27, 2024
Novel Treatment Strategies for Hormone Receptor (HR)-Positive, HER2-Negative Metastatic Breast CancerAntonella Ferro, Michela Campora, Alessia Caldara, et al.Bioscience Reports|December 3, 2019
P63 modulates the expression of the WDFY2 gene which is implicated in cancer regulation and limb developmentPaola Monti, Yari Ciribilli, Giorgia Foggetti, et al.Pageof 5